Related references
Note: Only part of the references are listed.Arsenic trioxide: New clinical experience with an old medication in hematologic malignancies
D Douer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective
CJ Lin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cardiac monitoring of patients receiving arsenic trioxide therapy
D Unnikrishnan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents
B Drolet et al.
CIRCULATION (2004)
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression
A Raza et al.
LEUKEMIA RESEARCH (2004)
Mechanisms of arsenic-induced prolongation of cardiac repolarization
E Ficker et al.
MOLECULAR PHARMACOLOGY (2004)
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma
O Hermine et al.
HEMATOLOGY JOURNAL (2004)
Effect of arsenic trioxide on QT interval in patients with advanced malignancies
JT Barbey et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
WY Au et al.
BLOOD (2003)
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Use of arsenic trioxide (AS2O3) in the treatment of patients with acute promyelocytic leukemia -: The M. D.!Anderson experience
G Lazo et al.
CANCER (2003)
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia
WY Au et al.
ANNALS OF ONCOLOGY (2003)
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
GKK Lau et al.
GASTROENTEROLOGY (2003)
Effects of sodium arsenite exposure on development and behavior in the rat
VM Rodríguez et al.
NEUROTOXICOLOGY AND TERATOLOGY (2002)
Prolongation of cardiac repolarization by arsenic trioxide
CE Chiang et al.
BLOOD (2002)
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report
DP Lu et al.
BLOOD (2002)
Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
K Ohnishi et al.
LEUKEMIA (2002)
Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
WY Au et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia
JT Barbey et al.
ANNALS OF INTERNAL MEDICINE (2001)
Arsenic inhibition of telomerase transcription leads to genetic instability
WC Chou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
P Westervelt et al.
BLOOD (2001)
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage
Y Shen et al.
LEUKEMIA (2001)
Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide
D Unnikrishnan et al.
BLOOD (2001)
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia
K Ohnishi et al.
ANNALS OF INTERNAL MEDICINE (2000)
Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide
O Galm et al.
LEUKEMIA (2000)
Share Paper
